-
OBIO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Orchestra BioMed (OBIO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 25.61 mm | 25.61 mm | 25.61 mm | 25.61 mm | 25.61 mm | 25.61 mm |
Cash burn (monthly) | (no burn) | (no burn) | 5.45 mm | 5.01 mm | 4.57 mm | 4.00 mm |
Cash used (since last report) | n/a | n/a | 23.21 mm | 21.34 mm | 19.46 mm | 17.04 mm |
Cash remaining | n/a | n/a | 2.40 mm | 4.26 mm | 6.15 mm | 8.56 mm |
Runway (months of cash) | n/a | n/a | 0.4 | 0.9 | 1.3 | 2.1 |
13F holders | Current |
---|---|
Total holders | 50 |
Opened positions | 7 |
Closed positions | 6 |
Increased positions | 20 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 94.91 bn |
Total shares | 26.60 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
RTW Investments | 8.21 mm | $42.18 bn |
MDT Medtronic | 5.87 mm | $45.07 mm |
Perceptive Advisors | 4.59 mm | $23.61 bn |
BlackRock | 1.94 mm | $9.98 bn |
HSAC 2 | 1.71 mm | $10.71 mm |
Vanguard | 1.31 mm | $6.73 bn |
Geode Capital Management | 567.22 k | $2.92 bn |
T. Rowe Price | 512.66 k | $2.64 mm |
STT State Street | 429.61 k | $2.21 bn |
Boxer Capital | 238.19 k | $1.22 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Chris Cleary | Common Stock, par value $0.0001 per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 10,155 | 0.00 | 10,155 |
3 Feb 25 | Chris Cleary | Stock Option Common Stock | Grant | Acquire A | No | No | 5.58 | 30,742 | 171.54 k | 30,742 |
27 Dec 24 | Aryeh Jason | Common Stock, par value $0.0001 per share ("Common Stock") | Option exercise | Acquire M | No | No | 4.3 | 11,700 | 50.31 k | 80,060 |
27 Dec 24 | Aryeh Jason | Stock Option Common Stock | Option exercise | Dispose M | No | No | 4.3 | 11,700 | 50.31 k | 6,900 |
23 Dec 24 | Hochman David P | Common Stock, par value $0.0001 per share ("Common Stock") | Buy | Acquire P | No | No | 4.66 | 4,000 | 18.64 k | 579,498 |
19 Dec 24 | Taylor Andrew Lawrence | Common Stock, par value $0.0001 per share | Buy | Acquire P | No | No | 4.83 | 1,000 | 4.83 k | 344,960 |